SCHEMBL26017258

SCHEMBL26017258

Nc1cccc2c1-c1ccccc1S2(c1ccccc1)c1ccccc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 3/20 0.40
PTPRC P08575 1/20 0.40
PABPC1 P11940 2/20 0.39
HSPA1A P0DMV8 1/20 0.39
ALDH1A1 P00352 3/20 0.38
L3MBTL1 Q9Y468 2/20 0.38
HSD17B10 Q99714 1/20 0.38
CSNK1A1 P48729 2/20 0.35
CSNK1D P48730 2/20 0.35
CSNK1G1 Q9HCP0 2/20 0.35
FGR P09769 1/20 0.35
PIM1 P11309 1/20 0.35
MAOA P21397 1/20 0.35
DYRK1A Q13627 1/20 0.35
HIPK2 Q9H2X6 1/20 0.35
PDK2 Q15119 1/20 0.33
SMN1; SMN2 Q16637 2/20 0.32
CYP3A4 P08684 1/20 0.32
ALOX15 P16050 1/20 0.32
CASP1 P29466 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26006768 0.79 ALDH1A1 (0.42) ADORA2APTPRCPABPC1HSPA1AALDH1A1
SCHEMBL21310568 0.78 ALDH1A1 (0.38) ALDH1A1L3MBTL1PDK2GPR3MEN1
SCHEMBL19734148 0.77 GPR3 (0.48) ALDH1A1GPR3MEN1KMT2AHTT
SCHEMBL20091624 0.75 GPR3 (0.46) PTPRCALDH1A1L3MBTL1HSD17B10MAOA
SCHEMBL21310579 0.75 CYP2A6 (0.39) ADORA2APTPRCALDH1A1SMN1; SMN2DPP4
SCHEMBL26017178 0.74 MAOA (0.41) PTPRCALDH1A1L3MBTL1HSD17B10MAOA
SCHEMBL17952657 0.73 GPR3 (0.58) ADORA2APTPRCPABPC1HSPA1AALDH1A1
SCHEMBL21310569 0.73 CYP1A2 (0.39) ADORA2AL3MBTL1CYP3A4MEN1KMT2A
SCHEMBL24292395 0.71 DNMT1 (0.40) ALDH1A1L3MBTL1HSD17B10SMN1; SMN2MEN1
SCHEMBL22947384 0.71 ADORA2A (0.40) ADORA2AALDH1A1L3MBTL1HSD17B10SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230269958-A1 ORGANIC COMPOUND, AND ELECTRONIC COMPONENT AND ELECTRONIC DEVICE HAVING SAME SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2023-08-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230269958-A1 ORGANIC COMPOUND, AND ELECTRONIC COMPONENT AND ELECTRONIC DEVICE HAVING SAME ORC3, PIEZO1, OR10J3 ADORA2A 4420/4885PTPRC 1420/4885PABPC1 1654/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.